![]() |
Bacteriology at UW-Madison |
Bacteriophage T4
Introduction
Viruses are smaller and less complex than bacteria. As science became aware of the role of the viruses in human disease, the techniques of bacteriology were modified to accomodate the viruses and the discipline of virology grew up within bacteriology. Because of this, we will begin this unit on viruses with bacteriophages, the viruses that infect bacterial cells. Animal viruses will be dealt with separately. But the lessons learned from the replication events of the bacteriophages will be directly applied to understanding the replication of viruses such as Herpes and HIV.
Viruses are the cause of many diseases in humans ranging from AIDS and cancer to the common cold. Microbiologists have developed vaccines for many viral diseases, but haven not been as successful in discovery of treatments for the diseases. It is the opposite in bacteriology, at least since the discovery of antibiotics. We have generally been able to treat bacterial disease, but besides the toxoid vaccines, vaccination against bacterial diseases has been hit-and-miss.
Biological Identity of Viruses
Viruses consist of nucleic acid (DNA or RNA) surrounded by a protein
coat called a capsid. The
capsid is
made up of individual structural subunits called capsomeres. Some viruses have
additional structural features, such as the envelope of animal viruses
or the tail of bacteriophages.
Figure
1. The most common viral morphologies. Left to Right. A naked
icosahedral
virus (e.g. poliovirus), an enveloped icosahedral virus (e.g. herpes
virus),
a naked helical virus (e.g. tobacco mosaic virus) and an enveloped
helical
virus (e.g. influenza virus). Individual capsomeres are arranged to
form
a capsid which encloses the nucleic acid (DNA or RNA) of the virus.
Many
animal viruses also contain an envelope, which is partly derived from
the
host cell membtrane but which always contains unique viral proteins
drawn
here as "spikes".
Viruses are considered obligate intracellular parasites because they require a host cell in order to replicate. The host cell may be any form of eucaryote or procaryote.
Viruses are noncellular entities that are not considered alive by
most microbiologists. They are very different from cells. Viruses lack
membranes and cannot produce energy; they lack enzymes for metabolic
functions; and they lack ribosomes for protein synthesis.
The general features of viruses are outlined in the table below.
Table 1.
General Features of Viruses
2. characteristic shapes - spherical (complex), helical, rod or polyhedral, sometimes with tails or envelopes. Most common polyhedron is the icosahedron which as 20 triangular faces.
3. obligate intracellular parasites Viruses do not contain within their coats the machinery for replication. For this they depend upon a host cell and this accounts for their existence as obligate intracellular parasites. Each virus can only infect certain species of cells. This refers to the virus host range.
4. no built-in metabolic machinery Viruses have no metabolic enzymes and cannot generate their own energy.
5. no ribosomes Viruses cannot synthesize their own proteins. For this they utilize host cell ribosomes during replication. Features 4 and 5 acccount for the obligate intracellular parasitism of viruses.
6. only one type of nucleic acid Viruses contain either DNA or RNA (never both) as their genetic material. The nucleic acid can be single-stranded or double stranded.
7. do not grow in size Unlike cells, viruses do not grow in
size and mass leading to a division process. Rather viruses grow by
separate synthesis and assembly of their components resulting in
production of a "crop" of mature viruses.
Viruses are classified on the basis of host range (see below), morphology (size, shape), type of nucleic acid (DNA, RNA, single-stranded, double-stranded, linear, circular, segmented, etc.) and occurrence of auxilliary structures such as tails or envelopes.
Host range refers to the the
type of cell in which the virus is able to replicate. In its broadest
sense host range arranges viruses into four groups: bacterial
viruses (bacteriophage), animal viruses, insect viruses
(bacculoviruses) and plant viruses. However, viruses in archaea,
protista, yeast, molds and fungi have also been described. In a
narrower sense, host range may be defined by specific species that
are infected by the virus. Thus, each bacterial virus only infects
certain
species of bacteria; each animal virus only infects certain species of
animals;
and so on. In a more limited sense, when a virus infects a
multicellular
organism, it usually infects only a certain type of cell in the
organism.
Hence, the rhinoviruses which cause the common cold only infect cells
of
the upper respiratory tract, and the human immunodeficiency virus (HIV)
only
infects primarily a specific type of cell (CD4+ cells) of the human
immune
system.
Figure
2. Comparative
size and shape of various groups of viruses representing
diversity of form and host range. A. Smallpox virus B. Orf
virus
C. Rhabdovirus D.
Paramyxovirus E. Bacteriophage T2 F. Flexuous-tailed
bacteriophage G. Herpes virus H. Adenovirus I.
Influenza virus J. Filamentous flexuous virus K.
Tobacco mosaic virus L. Polyoma/papilloma virus M.
Alflafa mosaic virus N. poliovirus O. Bacteriophage
phiX174. Viruses have fundamentally three morphologies: 1. polygonal,
the most common polygon being the icosahedron (E, F, G, H, L,
N); 2. helical, wherein the capsomeres assemble as a helix
enclosing the nucleic acid) (D, I, J, K, M; B is controversial);
3. complex, wherein the proteins are laid down in patches or
layers (A). Some animal viruses have envelopes which enclose
their nucleocapsid (D, G, I). The envelopes are embedded with viral
proteins that secre their entry and exit in cells. Only bacteriophages
have tails which are used for adsorption and penetration of their
host cell.
Figure
3. Gallery
of electron micrographs of viruses illustrating diversity
in form and structure. Clockwise: Human immunodeficiencyvirus (HIV);
Aeromonas
virus 31, Influenza virus, Orf virus, Herpes simplex virus (HSV),
Smallopx
virus.
The Bacteriophages
Viruses that attack bacteria were observed by Twort and d'Herelle in
1915 and 1917. They observed that broth cultures of certain intestinal
bacteria could be dissolved by addition of a bacteria-free filtrate
obtained from sewage. The lysis of the bacterial cells was said to be
brought about by a virus which meant a "filterable poison"
("virus" is Latin for "poison").
Probably every known bacterium is subject to infection by one or more
viruses or
"bacteriophages" as they are known ("phage" for short, from Gr.
"phagein" meaning "to eat" or "to nibble"). Most research has been done
on the phages that attack E. coli,
especially the T-phages and phage lambda.
Like most viruses, bacteriophages typically carry only the genetic
information
needed for replication of their nucleic acid and synthesis of their
protein coats. When phages infect their host cell, the order of
business is to replicate their nucleic acid and to produce the
protective protein coat. But they cannot do this alone. They require
precursors, energy generation and ribosomes supplied by their bacterial
host cell.
Bacterial cells can undergo one of two types of infections by viruses
termed lytic infections
and lysogenic (temperate)
infections. In E. coli,
lytic infections are caused by a group seven phages known as the
T-phages, while lysogenic infections are caused by the phage lambda.
Lytic Infections
The T-phages,
T1 through T7, are referred to as lytic phages because they
always bring about the lysis and death of their host cell, the
bacterium E. coli.
T-phages contain double-stranded DNA as their genetic material. In
addition to their protein coat or capsid (also referred to as the
"head"), T-phages also possess a tail and some related structures. A
diagram and electron micrograph of bacteriophage T4 is shown below. The
tail includes a core, a tail sheath, base plate, tail pins, and tail
fibers, all of which are composed of different proteins. The tail and
related structures of bacteriophages are generally involved in
attachment of the phage and securing the entry of the viral nucleic
acid into the host cell.

Figure
4.
Left.
Electron Micrograph of bacteriophage T4. Right. Model of phage T4. The
phage possesses a genome of linear ds DNA contained within an
icosahedral head. The tail consists of a hollow core through which the
DNA is injected into the host cell. The tail fibers are involved with
recognition of specific viral "receptors" on the bacterial cell surface.
Before viral infection, the cell is involved in replication of its own
DNA and
transcription and translation of its own genetic information to carry
out biosynthesis,
growth and cell division. After infection, the viral DNA takes over the
machinery of the host cell and uses it to produce the nucleic acids and
proteins needed for production of new virus particles. Viral DNA
replaces
the host cell DNA as a template for both replication (to produce more
viral DNA) and transcription (to produce viral mRNA). Viral mRNAs are
then translated, using host cell ribosomes, tRNAs and amino acids, into
viral proteins such as the coat or tail proteins. The process of DNA
replication, synthesis of proteins, and viral assembly is a carefully
coordinated and timed event. The overall process of lytic infection is
diagrammed in the figure below. Discussion of the specific steps
follows.

Figure
4.
The
lytic cycle of a bacterial virus, e.g. bacteriophage T4.
The first step in the replication of the phage in its host cell
is called adsorption. The
phage particle undergoes a chance
collision at a chemically complementary site on the bacterial surface,
then adheres to that site by means of its tail fibers.
Following adsorption, the phage injects its DNA into the bacterial
cell. The tail sheath contracts and the core is driven through the wall
to the membrane. This process is called penetration and it may be both
mechanical and enzymatic. Phage T4 packages a
bit of lysozyme in the base of its tail from a previous infection and
then uses the lysozyme to degrade a portion of the bacterial cell wall
for insertion of the tail core. The DNA is injected into the periplasm
of the bacterium, and generally it is not known how the DNA penetrates
the membrane. The adsorption and penetration processes are illustrated
below.

Figure
5.
Adsorption,
penetration and injection of bacteriophage T4 DNA
into an E. coli cell. T4
attaches to an outer membrane porin protein, ompC.
Immediately after injection of the viral DNA there is a process
initiated called synthesis of
early proteins. This refers to the
transcription and translation of a section of the phage DNA to make a
set of proteins that are needed to replicate the phage DNA. Among
the early proteins produced are a repair enzyme to repair the hole
in the bacterial cell wall, a DNAase enzyme that degrades the host DNA
into precursors of phage DNA, and a virus specific DNA polymerase that
will copy and replicate phage DNA. During this period the cell's
energy-generating and protein-synthesizing abilities are
maintained, but they have been subverted by the virus. The result is
the synthesis of several copies of
the phage DNA.
The next step is the synthesis of late proteins. Each of the
several replicated copies of the phage DNA can now be used for
transcription and translation of a second set of proteins called the
late proteins. The late
proteins are mainly structural proteins that
make up the capsomeres and the various components of the tail assembly.
Lysozyme is also a late protein that will be packaged in the tail of
the phage and be used to escape from the host cell during the last step
of the replication process.
Having replicated all of their parts, there follows an assembly
process. The proteins that make up the capsomeres assemble themselves
into the heads and "reel in" a copy of the phage DNA. The tail and
accessory structures assemble and incorporate a bit of lysozyme in the
tail plate. The viruses arrange their escape from the host cell during
the assembly process.
While the viruses are assembling, lysozyme is being produced as a late
viral protein. Part of this lysozome is used to escape from the host
cell by lysing the cell wall peptiodglycan from the inside. This
accomplishes the lysis of the
host cell and the release of
the mature
viruses, which spread to nearby cells, infect them, and complete
the
cycle. The life cycle of a T-phage takes about 25-35 minutes to
complete. Because the host cells are ultimately killed by lysis, this
type of viral infection is referred to a lytic infection.
Lysogenic Infections
Figure
6.
Bacteriophage
Lambda, the lysogenic phage that infects E. coli. Bock laboratories.
University of Wisconsin-Madison.

Lysogenic or temperate infection rarely results in lysis of the
bacterial host cell. Lysogenic viruses, such as lambda which
infects E. coli, have a
different strategy than lytic viruses for their
replication. After penetration, the virus DNA integrates
into the bacterial chromosome and it becomes replicated every
time the cell duplicates its chromosomal DNA during normal cell
division. The life cycle of a lysogenic bacteriophage is illustrated
below.

Figure
7.
The
lysogenic cycle of a temperate bacteriophage such as lambda.
Temperate viruses usually do not kill the host bacterial cells they
infect. Their chromosome becomes integrated into a specific section of
the host cell chromosome. Such phage DNA is called prophage and the host bacteria are
said to be lysogenized. In the
prophage state all the
phage genes except one are repressed. None of the usual early proteins
or structural proteins are formed.
The phage gene that is expressed is an important one because it codes
for the synthesis of a repressor
molecule that prevents the synthesis
of phage enzymes and proteins required for the lytic cycle. If the
synthesis
of the repressor molecule stops or if the repressor becomes
inactivated,
an enzyme encoded by the prophage is synthesized which excises the
viral DNA from the bacterial chromosome. This excised DNA (the phage
genome) can now behave like a lytic virus, that is to produce new viral
particles and eventually lyse the host cell (see diagram above). This
spontaneous derepression is a
rare event occurring about one in 10,000
divisions of a lysogenic bacterium., but it assures that new phage are
formed which can proceed to infect other cells.
Usually it is difficult to recognize lysogenic bacteria because
lysogenic and nonlysogenic cells appear identical. But in a few
situations, the prophage supplies genetic information such that the
lysogenic bacteria exhibit a new characteristic (new phenotype),
not displayed by the nonlysogenic cell, a phenomenon
called lysogenic conversion.
Lysogenic conversion has some
interesting manifestations in pathogenic bacteria that only exert
certain determinants of virulence when they are in a lysogenized state.
Hence, Corynebacterium
diphtheriae can only produce the toxin
responsible for the disease if it carries a temperate virus called
phage beta. Only lysogenized streptococci produce the
erythrogenic
toxin (pyrogenic exotoxin) which causes the skin rash of scarlet fever;
and some botulinum toxins are synthesized only by lysogenized
strains of C. botulinum.

Figure
8.
Corynebacterium
diphtheriae only produces
diphtheria toxin
when lysogenized by beta phage. C.
diphtheriae strains that
lack the prophage do not produce diphtheria toxin and do not cause the
disease diphtheria. Surprisingly, the genetic information for
production
of the toxin is found to be on the phage chromosome, rather than
the bacterial chromosome.
A similar phenomenon to lysogenic conversion exists in the relationship
between an animal tumor virus and its host cell. In both instances,
viral
DNA is incorporated into the host cell genome, and there is a
coincidental
change in the phenotype of the cell. Some human cancers may be caused
by viruses which establish a state in human cells analogous to lysogeny
in bacteria.
Phage Therapy
Phage therapy is the therapeutic use of lytic bacteriophages to treat
pathogenic bacterial infections. Phage therapy is an alternative to
antibiotics being developed for clinical use by research groups in
Eastern Europe and the U.S. After having been extensively used and
developed mainly in former Soviet Union countries for about 90 years,
phage therapies for a variety of bacterial and poly microbial
infections are now becoming available on an experimental basis in other
countries, including the U.S. The principles of phage therapy have
potential applications not only in human medicine, but also in
dentistry, veterinary science, food science and agriculture.
An important benefit of phage therapy is derived from the observation
that bacteriophages are much more specific than most antibiotics that
are in clinical use. Theoretically, phage therapy is harmless to the
eucaryotic host undergoing therapy, and it should not affect the
beneficial normal flora of the host. Phage therapy also has few, if
any, side effects, as opposed to drugs, and does not stress the liver.
Since phages are self-replicating in their target bacterial cell, a
single, small dose is theoretically efficacious. On the other hand,
this specificity may also be disadvantageous because a specific phage
will only kill a bacterium if it is a match to the specific subspecies.
Thus, phage mixtures may be applied to improve the chances of success,
or clinical samples can be taken and an appropriate phage identified
and grown.
Phages are currently being used therapeutically to treat bacterial
infections that do not respond to conventional antibiotics,
particularly in the country of Georgia. They are reported to be
especially successful where bacteria have constructed a biofilm
composed of a polysaccharide matrix that antibiotics cannot penetrate.